{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:04:46Z","timestamp":1789578286214,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10140022210043"],"award-info":[{"award-number":["10140022210043"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accurate and rapid diagnosis of early-onset neonatal sepsis (EOS) in preterm infants remains problematic due to a lack of specific symptoms and diagnostic tools. Following the Dutch EOS guidelines, over 80% of infants born\u2009&lt;\u200932\u00a0weeks of gestation are empirically started on antibiotics directly after birth, while the actual incidence of EOS varies between 1 and 2%. Unnecessary antibiotic exposure leads to severe short and long-term complications. The biomarker presepsin, also known as soluble CD14 subtype, may be used to reduce antibiotic prescription in preterm infants after birth. The objective of this study is to investigate whether adding a presepsin-guided decision to the guideline safely reduces antibiotic exposure directly after birth in preterm infants. Secondly, the diagnostic accuracy of presepsin for EOS will be evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The PRESAFE trial is a multicentre, randomized controlled trial (RCT), including a concurrent observational study. Presepsin levels are determined from umbilical cord blood or during the first regular blood draw in all infants born\u2009&lt;\u200932\u00a0weeks gestation. Infants who qualify for empirical antibiotics according to the Dutch EOS guideline are categorized as moderate or high risk for EOS based on prespecified high-risk criteria. Infants not qualifying for empirical antibiotics are categorized as low risk. Preterm infants with a moderate risk for EOS are randomized 1:1 into an intervention arm and a comparator arm. In infants allocated to the intervention arm, empirical antibiotics will only be started above a prespecified presepsin level of\u2009\u2265\u2009645\u00a0pg\/ml. In the comparator arm, infants will be treated according to the standard of care following the Dutch EOS guideline, equivalent to starting empirical antibiotics. The co-primary outcomes of the RCT are the incidence of culture-proven EOS (non-inferiority) and unnecessary antibiotics administration (superiority). The required sample size for the RCT is 900 patients. Infants with a high- or low-risk of EOS are excluded from randomization but included in a concurrent observational study and treated according to the Dutch EOS guideline. The primary outcome of this part is the diagnostic accuracy of presepsin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The findings of the RCT will provide evidence for safe and effective reduction of administration of antibiotics for suspected EOS in infants born\u2009&lt;\u200932\u00a0weeks of gestation. The observational study will provide more insight in the diagnostic accuracy of all infants born\u2009&lt;\u200932\u00a0weeks of gestation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT06100614. First registered on October 25, 2023.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-026-09515-8","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:05:23Z","timestamp":1772157923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Presepsin to safely reduce antibiotics in preterm infants (PRESAFE): study protocol for a randomized controlled trial with a concurrent observational study"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7923-1690","authenticated-orcid":false,"given":"Charlotte M.","family":"Nusman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Rob","family":"Taal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Vijlbrief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen W. G.","family":"van Mechelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem P.","family":"de Boode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke A. C.","family":"Hemels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen M. Lorente","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek M.","family":"Roescher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie H. G. M.","family":"Nuytemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia A.","family":"Obermann-Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"van der Flier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leti","family":"van Bodegom-Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian R. B.","family":"Ramakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H. M.","family":"Schotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corianne A. J. M.","family":"de Borgie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maruschka P.","family":"Merkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariska M. G.","family":"Leeflang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton H.","family":"van Kaam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wes","family":"Onland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douwe H.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"9515_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2020-320217","author":"C Fleischmann","year":"2021","unstructured":"Fleischmann C, Reichert F, Cassini A, Horner R, Harder T, Markwart R, et al. Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch Dis Child. 2021. https:\/\/doi.org\/10.1136\/archdischild-2020-320217.","journal-title":"Arch Dis Child"},{"key":"9515_CR2","unstructured":"Preventie en behandeling van early-onset neonatale infecties. Nederlandse Vereniging voor Kindergeneeskunde; 2017.\u00a0www.nvk.n\/kennisdocument\/preventie-en-behandeling-van-early-onset-neonatale-infecties\/."},{"key":"9515_CR3","doi-asserted-by":"crossref","unstructured":"Puopolo KM, Benitz WE, Zaoutis TE, Committee On F, Newborn, Committee On Infectious D. Management of Neonates Born at <\/=34 6\/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics. 2018;142(6):e20182896.","DOI":"10.1542\/9781610023047-part05-management_of_neonates"},{"key":"9515_CR4","doi-asserted-by":"crossref","unstructured":"Duggan HL, Chow SSW, Austin NC, Shah PS, Lui K, Tan K, et al. Early-onset sepsis in very preterm neonates in Australia and New Zealand, 2007\u20132018. Arch Dis Child Fetal Neonatal Ed. 2022;108(1):31\u20137.","DOI":"10.1136\/archdischild-2021-323243"},{"issue":"1","key":"9515_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1542\/peds.2007-3423","volume":"123","author":"CM Cotten","year":"2009","unstructured":"Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sanchez PJ, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123(1):58\u201366.","journal-title":"Pediatrics"},{"issue":"1","key":"9515_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06352-3","volume":"23","author":"MJ Morowitz","year":"2022","unstructured":"Morowitz MJ, Katheria AC, Polin RA, Pace E, Huang DT, Chang CH, et al. The NICU antibiotics and outcomes (NANO) trial: a randomized multicenter clinical trial assessing empiric antibiotics and clinical outcomes in newborn preterm infants. Trials. 2022;23(1):428.","journal-title":"Trials"},{"issue":"3","key":"9515_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/jac\/dkx426","volume":"73","author":"JW Fjalstad","year":"2018","unstructured":"Fjalstad JW, Esaiassen E, Juvet LK, van den Anker JN, Klingenberg C. Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review. J Antimicrob Chemother. 2018;73(3):569\u201380.","journal-title":"J Antimicrob Chemother"},{"key":"9515_CR8","doi-asserted-by":"crossref","unstructured":"Dierikx TH, Deianova N, Groen J, Vijlbrief DC, Hulzebos C, de Boode WP, et al. Association between duration of early empiric antibiotics and necrotizing enterocolitis and late-onset sepsis in preterm infants: a multicenter cohort study. Eur J Pediatr. 2022;181(10):3715\u20133724.","DOI":"10.1007\/s00431-022-04579-5"},{"key":"9515_CR9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2286","author":"JY Ting","year":"2019","unstructured":"Ting JY, Roberts A, Sherlock R, Ojah C, Cieslak Z, Dunn M, et al. Duration of initial empirical antibiotic therapy and outcomes in very low birth weight infants. Pediatrics. 2019. https:\/\/doi.org\/10.1542\/peds.2018-2286.","journal-title":"Pediatrics"},{"issue":"1","key":"9515_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.gastro.2016.03.006","volume":"151","author":"FI Scott","year":"2016","unstructured":"Scott FI, Horton DB, Mamtani R, Haynes K, Goldberg DS, Lee DY, et al. Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity. Gastroenterology. 2016;151(1):120-9 e5.","journal-title":"Gastroenterology."},{"issue":"11","key":"9515_CR11","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1046\/j.1365-2222.2000.00939.x","volume":"30","author":"JH Droste","year":"2000","unstructured":"Droste JH, Wieringa MH, Weyler JJ, Nelen VJ, Vermeire PA, Van Bever HP. Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin Exp Allergy. 2000;30(11):1547\u201353.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"9515_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-019-0298-8","volume":"20","author":"I van Maldeghem","year":"2019","unstructured":"van Maldeghem I, Nusman CM, Visser DH. Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis. BMC Immunol. 2019;20(1):17.","journal-title":"BMC Immunol"},{"issue":"8","key":"9515_CR13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/jamapediatrics.2022.1647","volume":"176","author":"C Poggi","year":"2022","unstructured":"Poggi C, Lucenteforte E, Petri D, De Masi S, Dani C. Presepsin for the diagnosis of neonatal early-onset sepsis: a systematic review and meta-analysis. JAMA Pediatr. 2022;176(8):750\u20138.","journal-title":"JAMA Pediatr"},{"issue":"3","key":"9515_CR14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/antibiotics12030489","volume":"12","author":"TH Dierikx","year":"2023","unstructured":"Dierikx TH, van Laerhoven H, van der Schoor SRD, Nusman CM, Lutterman CAM, Vliegenthart RJS, et al. Can Presepsin Be Valuable in Reducing Unnecessary Antibiotic Exposure after Birth? Antibiotics. 2023;12(3):489.","journal-title":"Antibiotics"},{"key":"9515_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101270","volume":"44","author":"L Snoek","year":"2022","unstructured":"Snoek L, van Kassel MN, Krommenhoek JF, Achten NB, Plotz FB, van Sorge NM, et al. Neonatal early-onset infections: comparing the sensitivity of the neonatal early-onset sepsis calculator to the Dutch and the updated NICE guidelines in an observational cohort of culture-positive cases. EClinicalMedicine. 2022;44:101270.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"9515_CR16","doi-asserted-by":"publisher","first-page":"e2036518","DOI":"10.1001\/jamanetworkopen.2020.36518","volume":"4","author":"N Fleiss","year":"2021","unstructured":"Fleiss N, Coggins SA, Lewis AN, Zeigler A, Cooksey KE, Walker LA, et al. Evaluation of the Neonatal Sequential Organ Failure Assessment and Mortality Risk in Preterm Infants With Late-Onset Infection. JAMA Netw Open. 2021;4(2):e2036518.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"9515_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41390-019-0517-2","volume":"88","author":"JL Wynn","year":"2020","unstructured":"Wynn JL, Polin RA. A neonatal sequential organ failure assessment score predicts mortality to late-onset sepsis in preterm very low birth weight infants. Pediatr Res. 2020;88(1):85\u201390.","journal-title":"Pediatr Res"},{"issue":"1","key":"9515_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0031-3955(16)34975-6","volume":"33","author":"MC Walsh","year":"1986","unstructured":"Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33(1):179\u2013201.","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"9515_CR19","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"9515_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.jp.7210963","volume":"23","author":"MC Walsh","year":"2003","unstructured":"Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol. 2003;23(6):451\u20136.","journal-title":"J Perinatol"},{"key":"9515_CR21","unstructured":"Volpe JJ, Inder TE, Darras BT, de Vries LS, du Plessis AJ, Neil J, et al. Neurology of the Newborn. 6th ed. 2017."},{"issue":"10","key":"9515_CR22","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","volume":"128","author":"MF Chiang","year":"2021","unstructured":"Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, et al. International classification of retinopathy of prematurity, third edition. Ophthalmology. 2021;128(10):e51\u201368.","journal-title":"Ophthalmology"},{"key":"9515_CR23","doi-asserted-by":"crossref","unstructured":"Halbmeijer NM, Sonnaert M, Swarte RM, Koopman-Esseboom C, van Stuijvenberg M, Mulder-de Tollenaer S, et al. Identifying effect modifiers of systemic hydrocortisone treatment initiated 7\u201314 days after birth in ventilated very preterm infants on long-term outcome: secondary analysis of a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2023;109(2):159\u2013165.","DOI":"10.1136\/archdischild-2023-325558"},{"issue":"10097","key":"9515_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0140-6736(17)31444-7","volume":"390","author":"M Stocker","year":"2017","unstructured":"Stocker M, van Herk W, El Helou S, Dutta S, Fontana MS, Schuerman F, et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet. 2017;390(10097):871\u201381.","journal-title":"Lancet"},{"issue":"14","key":"9515_CR25","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1056\/NEJMra1510063","volume":"377","author":"L Mauri","year":"2017","unstructured":"Mauri L, D\u2019Agostino RB Sr. Challenges in the Design and Interpretation of Noninferiority Trials. N Engl J Med. 2017;377(14):1357\u201367.","journal-title":"N Engl J Med"},{"key":"9515_CR26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-4322","author":"T Ho","year":"2018","unstructured":"Ho T, Buus-Frank ME, Edwards EM, Morrow KA, Ferrelli K, Srinivasan A, et al. Adherence of newborn-specific antibiotic stewardship programs to CDC recommendations. Pediatrics. 2018. https:\/\/doi.org\/10.1542\/peds.2017-4322.","journal-title":"Pediatrics"},{"issue":"3","key":"9515_CR27","doi-asserted-by":"publisher","first-page":"F327","DOI":"10.1136\/archdischild-2018-315412","volume":"104","author":"S Mukhopadhyay","year":"2019","unstructured":"Mukhopadhyay S, Sengupta S, Puopolo KM. Challenges and opportunities for antibiotic stewardship among preterm infants. Arch Dis Child Fetal Neonatal Ed. 2019;104(3):F327\u201332.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"12","key":"9515_CR28","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1080\/14767058.2017.1322060","volume":"31","author":"D Sharma","year":"2018","unstructured":"Sharma D, Farahbakhsh N, Shastri S, Sharma P. Biomarkers for diagnosis of neonatal sepsis: a literature review. J Matern Fetal Neonatal Med. 2018;31(12):1646\u201359.","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09515-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09515-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09515-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:49:21Z","timestamp":1775036961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09515-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9515"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09515-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7240890\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is conducted according to the principles of the Declaration of Helsinki and in accordance with Dutch law (Medical Research Involving Human Subjects Act). The study protocol (study ID number NL85180.018.24) is evaluated and approved by the MREC of the Amsterdam UMC (reference 2024.0085). Parental consent is desirable before study participation, but can in exceptions be acquired in a two-stage consent or deferred consent procedure (see \"\n                      \n                      \"). Written informed consent will be obtained within 48\u00a0h after birth.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"267"}}